<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Yusuf, Salim</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">PURE: CV Drugs Underused for Secondary Prevention in Poor and Rural Populations</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">Despite proven efficacy and relatively low cost, key secondary prevention medications are widely underused in populations with prevalent cardiovascular disease particularly in poor countries and rural areas, according to findings from the Prospective Urban Rural Epidemiological [PURE] study.</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>